Ariene Bréant

Director of Global Market Development at Shockwave Medical Inc.

[Shockwave Medical @ShockwaveIVL]

Kudos to Dr Tom Noel, Dr Bill Dixon and the whole team at Tallahassee Memorial Hospital in Florida for enrolling their first patient in the COSIRA II trial! A special thank you to Dr Shmuel Banai for his support in the first randomized, blinded case.
To learn more about the COSIRA II trial and the participating sites visit https://t.co/TAt8wltjki

ISI https://t.co/x46wohjBQF Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

[Shockwave Medical @ShockwaveIVL]

We’re pleased to announce the completion of Johnson & Johnson’s acquisition of Shockwave Medical and congratulate our current Chief Commercial Officer and President, Isaac Zacharias, on being named Worldwide President of Shockwave within @JNJMedTech.

The #ShockNation team is excited to make even bigger waves as part of J&J MedTech as we continue to pioneer new technologies, disrupt the standard of care and transform patient lives, together with our physician partners.

Read more in the Press Release: https://t.co/vSmz91LJfs

#JNJMedTechProud #ShockOn @JNJNews

[Shockwave Medical @ShockwaveIVL]

Congratulations to Dr. Michael Foley and the investigators for the ORBITA-COSMIC trial (PI @rallamee). The trial resulted in reduced angina frequency and improved heart disease related quality of life. And while the imaging endpoint showed no improvement in transmural myocardial perfusion, it did show improvement in subendocardial perfusion, supporting the theorized mechanism of action of the #ShockwaveReducer.

@ACCinTouch
ISI https://t.co/x46wohk9Gd ​Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

[Shockwave Medical @ShockwaveIVL]

Inspiring patient story from Prof Jan-Malte Sinning & team at Cellitinnen-Krankenhaus St. Vinzenz in Cologne, Germany. We’re thrilled to hear the #ShockwaveReducer helped make your patient feel better, get back on his feet and back in the karate dojo. Congratulations to everyone involved.

See his post: https://t.co/CDQpplEp20

International customers: learn more about the Coronary Sinus Reducer at https://t.co/Y1kol6JRLR

ISI https://t.co/x46wohk9Gd
Individual patient experiences will vary.
Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

[Shockwave Medical @ShockwaveIVL]

Presented today at #ACC24 Congress, the six-month results from the REDUCER-I Trial add to positive evidence of the Coronary Sinus Reducer to treat refractory angina.

Read the Press Release to learn more: https://t.co/xgSRNSEaOS

@ACCinTouch #ShockwaveReducer
ISI https://t.co/x46wohk9Gd ​Caution: Investigational Device. Limited by U.S. and Canadian law to investigational use. The Reducer is commercially available in certain countries outside the U.S. and Canada. Please contact your local representative for specific country availability.

[Shockwave Medical @ShockwaveIVL]

To our international customers: Congratulations Dr. Eleonora Gnan et al on your presentation during #ESCCongress on how the Coronary Sinus #Reducer is impactful for patients with microvascular angina.

ISI https://t.co/sZ0NdzXNcV @escardio #CardioTwitter

[Shockwave Medical @ShockwaveIVL]

Want to learn more about the role of #ShockwaveIVL in CTOs? Join us at @crfheart #CTO2023 as Drs. @JAG24851 @RhianEDavies1 @cghanratty @cardiofrizz @perc_surgeon & Mike Wyman break down the merits & limitations of #IVL in CTOs: https://t.co/IFgZhwMwDT

ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

Ever wonder what happens long-term to the transmural cracks following #ShockwaveIVL? You gotta see it to believe it. Check out an #OCT visualization of IVL’s healing process over 1 year by Dr @ziadalinyc et al in @JACCJournals: https://t.co/PeDc2JwQyC

ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

Tomorrow at 5:10 PM (GMT+8) don’t miss the #ShockwaveIVL launch symposium at #TTT2023 in Taipei. Dr @HontonB and Dr Wei-Hsian Yin will discuss the benefits of #CoronaryIVL for calcified coronary lesions supported by two live-in-a-box case sessions.

ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

With #ShockwaveIVL you can get a new approach to tackling calcified disease in large vessels. Watch Shockweek Ep 1 on @Vascupedia_com where Drs @farkomd @Dr_Bisdas Coscas & Noory will share the benefits of IVL in iliac access.
https://t.co/GyCzP6p6uV

ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

Congratulations to Drs. Jeng Wei, Tien-Ping Tsao, Wei-Hsian Yin and Hsu-Lung Jen on performing the first #ShockwaveIVL cases in Taiwan! 🇹🇼 A milestone accomplishment for you, Cheng Hzin General Hospital in Taipei, and the patients you helped.

ISI https://t.co/sZ0NdzYl2t

[Shockwave Medical @ShockwaveIVL]

PARTIU CÁLCIO! Congratulations to Dr. Alexandre Araujo Pereira and team at Hospital Moinhos de Vento on the 1st #ShockwaveIVL treatment of peripheral arteries in southern Brazil. Excellent result & nice cracks visible on #IVUS.

ISI https://t.co/sZ0NdzYl2t
https://t.co/2bJ4MVG1or

[Shockwave Medical @ShockwaveIVL]

Interested in learning the Top 5 Tips for #ShockwaveIVL Optimization? Drs @mhumphriesmd & @DrLizGenovese share how to maximize Shockwave’s MOA to improve results with peripheral Ca++ modification in the latest @hmpVDM video: https://t.co/JrPNIdzMpX

ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

Find out why Dr Jaikirshan Khatri of @CleveClinicCath, while discussing calcium modification tool selection, shares that “#ShockwaveIVL can simplify problems that otherwise are relatively risky to deal with.”
Read more: https://t.co/RXvJ52YrPs

ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

Take a fresh approach to tackling calcified disease in large vessels. Today, in four hours, tune in on @Vascupedia_com for a live case and panel discussion with Drs Elias Noory @Dr_Bisdas @farkomd & Raphael Coscas. Watch here: https://t.co/0WHf3vb4SK

ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

Congrats to Dr Praveen Chandra, Chairman of Interventional Cardiology at Medanta Hospital, on being the first physician in India to treat 100 patients with #ShockwaveIVL! A momentous accomplishment for you, your institution & the @Translumina_in team.
ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

Congratulations to Prof. Chen Zhong & team at Beijing Anzhen Hospital on the 1st #PeripheralIVL case in China! Severe iliac calcification treated with #ShockwaveM5 to an excellent outcome. Look at the final angio and 1 week follow-up!

ISI https://t.co/sZ0NdzXNcV #ShockwaveIVL

[Shockwave Medical @ShockwaveIVL]

At #Breakthroughs22, #ShockwaveIVL was announced a winner of @PremierHA’s Supplier Horizon Award, recognizing Shockwave’s commitment to drive value through clinical excellence & commitment to lower costs.
Read about the award: https://t.co/03Hz2a23To

ISI https://t.co/sZ0NdzXNcV

[Shockwave Medical @ShockwaveIVL]

We hope this research grant, sponsored by @SCAI and #ShockwaveIVL, improves knowledge & understanding of calcified lesions and further informs us of gender, race and age disparities in coronary calcium modification outcomes.

ISI https://t.co/sZ0NdzXNcV
https://t.co/OVmUslLxl1

[Shockwave Medical @ShockwaveIVL]

In his Q&A, Dr @HontonB describes the impact the 1-Year #OCT Patient-level Pooled Analysis has on the interventional cardiology community and in the treatment of calcified #CAD patients. Read his insights today!

ISI https://t.co/sZ0NdzXNcV #CardioTwitter
https://t.co/zUc4h9y7tn